# Everolimus

NDC: 0054-0604
Generic name: Everolimus
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20211118

FDA application: ANDA206133

## Active ingredients

- EVEROLIMUS: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0604"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0604
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf2dd54b-7a1d-4401-9a01-75e68235e433